Latest AbioMed Stories
NEW YORK, Sept.
An official with Massachusetts headquartered Abiomed Inc. says the company's new artificial heart has been successfully implanted in a patient. Abiomed chief executive Michael R.
Abiomed, Inc. (NASDAQ: ABMD) announced today that on Monday, November 10, 2008, the Company will release second fiscal quarter 2009 results. The Company will host a conference call to discuss the results on Monday, November 10, 2008, at 8:00 a.m. ET. Michael R.
-- Investor and Analyst Meeting on October 13 from 5:30 - 6:30 p.m. -- Customer Symposium Featuring Leading Clinician Presentations on October 13 from 7:00 - 9:30 p.m.
The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.